We differentiate between malignant and normal epithelia, identify a stromal inflammatory response driven by WNT5A, characterize a subgroup of BCC keratinocytes that overexpress heat shock proteins, and provide data supporting the heat shock protein (HSP) pathway as a potential novel therapeutic target for BCC. This evidence concerns the gene WNT5A and skin basal cell carcinoma.